These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 15567992)
1. Views on neurodegeneration as a basis for neuroprotective strategies. Riedlerer PF Med Sci Monit; 2004 Dec; 10(12):RA287-90. PubMed ID: 15567992 [TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336 [TBL] [Abstract][Full Text] [Related]
3. Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease. Zecca L; Casella L; Albertini A; Bellei C; Zucca FA; Engelen M; Zadlo A; Szewczyk G; Zareba M; Sarna T J Neurochem; 2008 Aug; 106(4):1866-75. PubMed ID: 18624918 [TBL] [Abstract][Full Text] [Related]
4. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease. Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease. Watanabe Y; Himeda T; Araki T Med Sci Monit; 2005 Jan; 11(1):RA17-23. PubMed ID: 15614202 [TBL] [Abstract][Full Text] [Related]
6. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease. Lastres-Becker I; Molina-Holgado F; Ramos JA; Mechoulam R; Fernández-Ruiz J Neurobiol Dis; 2005; 19(1-2):96-107. PubMed ID: 15837565 [TBL] [Abstract][Full Text] [Related]
7. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease? Chu Y; Kordower JH Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279 [TBL] [Abstract][Full Text] [Related]
9. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Jiang H; Luan Z; Wang J; Xie J Neurochem Int; 2006 Nov; 49(6):605-9. PubMed ID: 16806586 [TBL] [Abstract][Full Text] [Related]
12. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857 [TBL] [Abstract][Full Text] [Related]
13. Generation of a alpha-synuclein-based rat model of Parkinson's disease. Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315 [TBL] [Abstract][Full Text] [Related]
14. Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra. Mori F; Nishie M; Kakita A; Yoshimoto M; Takahashi H; Wakabayashi K J Neuropathol Exp Neurol; 2006 Aug; 65(8):808-15. PubMed ID: 16896314 [TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates. Purisai MG; McCormack AL; Langston WJ; Johnston LC; Di Monte DA Neurobiol Dis; 2005 Dec; 20(3):898-906. PubMed ID: 16006134 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease. Zhang D; Anantharam V; Kanthasamy A; Kanthasamy AG J Pharmacol Exp Ther; 2007 Sep; 322(3):913-22. PubMed ID: 17565007 [TBL] [Abstract][Full Text] [Related]
18. Dopamine complexes of iron in the etiology and pathogenesis of Parkinson's disease. Arreguin S; Nelson P; Padway S; Shirazi M; Pierpont C J Inorg Biochem; 2009 Jan; 103(1):87-93. PubMed ID: 18976814 [TBL] [Abstract][Full Text] [Related]
19. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice. Aoki E; Yano R; Yokoyama H; Kato H; Araki T Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004 [TBL] [Abstract][Full Text] [Related]
20. Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway. Marchetti B; Serra PA; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Cioni S; Gennuso F; Rocchitta G; Desole MS; Mazzarino MC; Miele E; Morale MC Ann N Y Acad Sci; 2005 Dec; 1057():296-318. PubMed ID: 16399902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]